Testing effectiveness (Phase 2)Study completedNCT00911300
What this trial is testing
Evaluation of Fondaparinux in Patients With a Heart Rhythm Disturbance Who Undergo Restoration of Normal Heart Rhythm
Who this might be right for
Fibrillation, Atrial
GlaxoSmithKline 349